Data as of Dec 06
| +0.01 / +0.27%|
The 2 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +36.61% increase from the last price of 3.66.
The current consensus among 4 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.